Treatment of NSCLC with iressa 250mg tablet

    23
    by Magicine Pharma
    Published: November 24, 2025 (3 weeks ago)

    It’s an anti-neoplastic drug and it is a tyrosine kinase inhibitor and having a active ingredient Gefitinib. Treatment of non-small cell lung cancer [NSCLC] with Iressa 250mg Tablet is helpful to the patient’s having this type of cancer. NSCLC is depicted by the uncontrolled and abnormal multiplication of cells within the lung tissues. To know more about this medication and to purchase it online without hustling in offline stores do visit Magicine Pharma Site.